PCV6 MODELED ACHIEVEMENT OF OPTIMAL LIPID VALUES WITH EXTENDED-RELEASE NIACIN/LOVASTATIN VERSUS SIMVASTATIN/EZETIMIBE COMBINATION THERAPY IN AT-RISK PATIENTS
May 1, 2006, 00:00
10.1016/S1098-3015(10)64676-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)64676-1/fulltext
Title :
PCV6 MODELED ACHIEVEMENT OF OPTIMAL LIPID VALUES WITH EXTENDED-RELEASE NIACIN/LOVASTATIN VERSUS SIMVASTATIN/EZETIMIBE COMBINATION THERAPY IN AT-RISK PATIENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64676-1&doi=10.1016/S1098-3015(10)64676-1
First page :
Section Title :
Open access? :
No
Section Order :
84